Compare Ryanair Holdings plc (RYAAY) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ryanair Holdings plc vs Teladoc Health Inc — how do they compare? Ryanair Holdings plc trades at $54.25 (market cap $27.24B), while Teladoc Health Inc trades at $6.09 (market cap $1.11B). The key difference: Ryanair Holdings plc is far larger — about 24.5× Teladoc Health Inc's market cap, and Ryanair Holdings plc pays a 1.66% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| RYAAY | TDOC | |
|---|---|---|
Market Cap | $27.24B | $1.11B |
Sector | Industrials | Health |
52-Week High | $73.82 | $9.72 |
52-Week Low | $53.24 | $4.47 |
Enterprise Value | $24.19B | $1.37B |
Dividend Yield | 1.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RYAAY trades at $54.37, down 1.79% today, with bearish technical signals but strong fundamentals including 12.13% net margins and 22.41% ROE. Recent earnings show mixed results with a Q1 beat but Q2 miss, while Q3 expectations are high at $3.38 EPS. The company maintains robust cash flow from operations at $3.42B despite net cash flow turning negative in 2025. Analyst consensus remains positive with 62.5% buy ratings, though recent news highlights concerns about oil price exposure and reduced traffic forecasts.
The outlook balances strong profitability and market position against near-term headwinds from fuel costs and competitive pricing. Investment opportunity lies in Ryanair's industry-leading efficiency and potential market share gains during industry consolidation. Key risks include unhedged fuel costs, winter capacity cuts, and macroeconomic sensitivity. The stock's current valuation at 13.04 P/E appears reasonable if the company can maintain its earnings trajectory amid industry challenges.
TDOC trades at $6.26, down 0.32% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $200.32 million in 2025, though revenue remains stable at $2.53 billion. Analyst consensus is a hold with a $8.88 price target, while recent news highlights leadership changes and ongoing legal investigations.
The outlook is cautious; while valuation ratios like P/S of 0.45 and EV/EBITDA of 6.5 appear attractive, persistent losses and negative ROE of -12.99% pose risks. Upside depends on profitability improvements under new CFO Michael Grasher, but investor sentiment is tempered by weak earnings and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ryanair Holdings plc
Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
